Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Alliance Data ( ADS) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call.

American Electric ( AEP) downgraded at Citigroup from Buy to Hold, Citigroup said. $38 price target. Company is facing higher regulatory risks in Ohio.

Aetna ( AET) rated new Neutral at Susquehanna. Valuation call, based on a $36 price target.

Dominion Resources ( D) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $46.50 price target. Company can deliver strong regulated growth.

Consolidated Edison ( ED) downgraded at Goldman to Sell, Goldman Sachs said. Valuation call.

FedEx ( FDX) rated new Buy at Citigroup. Company has strong potential earnings leverage.

Gen-Probe ( GPRO) downgraded at RBC from Outperform to Sector Perform, RBC Capital said. Valuation call, based on a $58 price target.

Hasbro ( HAS) rated new Buy at Jefferies. $61 price target. Company is leveraging its brands to expand beyond traditional toys.

Health Net ( HNT) downgraded at Cowen to Neutral, Cowen said. Valuation call.

IAC/InterActiveCorp ( IACI) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $33 price target. Valuation call, as the stock is up 38% over the past year.

Illumina ( ILMN) downgraded at RBC from Outperform to Sector Perform, RBC Capital said. Stock lacks near-term catalysts. $65 price target.

Life Technologies ( LIFE) downgraded at RBC from Outperform to Sector Perform, RBC Capital said. Valuation call, based on a $54 price target.

Mattel ( MAT) rated new Buy at Jefferies with a Buy rating, Jefferies said. $28 price target. Company is managing costs and is a market leader for younger children.

MGM Resorts ( MGM) upgraded at Citigroup from Sell to Hold, Citigroup said. Company refinanced its CityCenter debt and Las Vegas is showing signs of a recovery.

Merck ( MRK) downgraded at Citigroup from Buy to Hold, Citigroup said. $39 price target. Company is halting progress on Vorapaxar, which was its best near-term prospect.

Marathon Oil ( MRO) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Stock is already pricing in a spin-off of the refining assets. $45 price target.

If you liked this article you might like

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Why You Keep Cash on Hand; No Downside Conviction -- Jim Cramer's Top Thoughts